Assistant professor

MIT Technology Review's signature AI conference, EmTech Digital, comes to London April 16-17, 2024

Retrieved on: 
Tuesday, April 9, 2024
Renew Europe, European Parliament, Business, MIT, Ethics, Meta, Research, National Cyber Security Centre, Democracy, Life, MIT Technology Review, Legacy of Alan Turing, Parliament, European, Safety, Intelligence, Artificial Intelligence Act, Alan Turing Institute, Government, Policy, NCSC, Assistant professor, Medical device

CAMBRIDGE, Mass., April 9, 2024 /PRNewswire/ -- For the first time MIT Technology Review brings its signature AI conference, EmTech Digital, to Europe from 16-17 April in London, United Kingdom. Joining MIT Technology Review's editorial experts on the stage are leaders from Google DeepMind, Meta, BT, the Alan Turing Institute, the European Parliament, and the UK government. This conference will look at harnessing the power of AI and innovation through the lens of safety and global challenges.

Key Points: 
  • MIT's largest AI conference comes to London for the first time, as generative AI continues to dominate the public consciousness and questions surrounding ethics and responsibility grow.
  • CAMBRIDGE, Mass., April 9, 2024 /PRNewswire/ -- For the first time MIT Technology Review brings its signature AI conference, EmTech Digital , to Europe from 16-17 April in London, United Kingdom.
  • Joining MIT Technology Review's editorial experts on the stage are leaders from Google DeepMind, Meta, BT, the Alan Turing Institute, the European Parliament, and the UK government.
  • The two-day conference will be in-person in City of London, London and on-demand for attendees from around the world.

AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE

Retrieved on: 
Thursday, April 4, 2024
Research, Medical Devices, Surgery, FDA, Cardiology, General Health, Health, Science, Oncology, Other Science, Interventional radiology, RV, Pulmonary embolism, Thrombus, Associate, Partnership, Cannula, Patient, PERT, Cancer, APEX, Assistant professor, Bleeding, Safety, UCLA, Embolism, Pharmaceutical industry

The expanded FDA indication allows for the utilization of the AlphaVac F1885 System for the treatment of PE, which broadens the applicability of the AlphaVac F1885 System in the non-surgical removal of thrombi or emboli from the venous vasculature.

Key Points: 
  • The expanded FDA indication allows for the utilization of the AlphaVac F1885 System for the treatment of PE, which broadens the applicability of the AlphaVac F1885 System in the non-surgical removal of thrombi or emboli from the venous vasculature.
  • The indication expands treatment options for patients with PE, reducing thrombus burden and improving right ventricular function.
  • “The addition of the AlphaVac System in the mechanical thrombectomy world is a critical step forward in the treatment of PE patients,” said Dr. Keeling.
  • “The 510(k) clearance of the AlphaVac System represents an important milestone towards the treatment of PE,” said Mona Ranade, MD, Assistant Professor, Interventional Radiology, at the David Geffen School of Medicine at UCLA.

Renowned Los Angeles Urologist Dr. Justin Houman Appointed Assistant Professor at Cedars-Sinai Medical Center

Retrieved on: 
Wednesday, March 20, 2024
Diagnosis, Peyronie's disease, Health, Infertility, Prostate cancer, Assistant, Knowledge, Research, Fertility, Patient, Suite, Male, Cedars-Sinai Medical Center, Publication, Urinary tract infection, Erectile dysfunction, LOS, Kidney, Assistant professor

LOS ANGELES, March 20, 2024 /PRNewswire-PRWeb/ -- Cedars-Sinai Medical Center proudly announces the appointment of Dr. Justin Houman, a distinguished Los Angeles-based urologist, as Assistant Professor in the esteemed Department of Urology. With a wealth of experience in clinical practice, research, and medical education, Dr. Houman's appointment marks a significant addition to Cedars-Sinai's renowned team.

Key Points: 
  • Dr. Justin Houman, M.D., brings expertise in clinical care, research, and medical education to Cedars-Sinai's Department of Urology.
  • LOS ANGELES, March 20, 2024 /PRNewswire-PRWeb/ -- Cedars-Sinai Medical Center proudly announces the appointment of Dr. Justin Houman, a distinguished Los Angeles-based urologist , as Assistant Professor in the esteemed Department of Urology.
  • With a wealth of experience in clinical practice, research, and medical education, Dr. Houman's appointment marks a significant addition to Cedars-Sinai's renowned team.
  • In his role as Assistant Professor, Dr. Houman will impart invaluable knowledge and mentorship to medical students, residents, and fellows in urology.

Study Shines Light on Drill-interseeded Cover Crops in Corn

Retrieved on: 
Wednesday, March 20, 2024
Pennsylvania State University, Carbon, Architecture, Soil, Assistant professor, Agriculture

WESTMINSTER, Colo., March 20, 2024 /PRNewswire-PRWeb/ -- Recently published research in the journal Weed Science highlights potential best practices for drill-interseeding cover crops into corn in Northeast U.S. production regions. While drill-interseeding is emerging as a viable way to establish cover crops for northern corn growers, the challenge is to optimize both cover-crop establishment and corn yields, while minimizing weed growth.

Key Points: 
  • While drill-interseeding is emerging as a viable way to establish cover crops for northern corn growers, the challenge is to optimize both cover-crop establishment and corn yields, while minimizing weed growth.
  • While drill-interseeding is emerging as a viable way to establish cover crops for northern corn growers, the challenge is to optimize both cover-crop establishment and corn yields, while minimizing weed growth.
  • row spacing, can balance cover crop and corn production management goals, while placing cover crops at a relative fitness advantage over weeds," says John Wallace, Ph.D., Pennsylvania State University.
  • ), and interseeding timing (V3, V6) on light transmittance and the corresponding relative fitness of cover crops, weeds, and corn grain yields.

Pan American Energy Partners With The University Of Nevada, Reno For Comprehensive Metallurgical Testing And Research

Retrieved on: 
Monday, March 4, 2024
Lithium, Magnesium, Temperature, Sustainability, News, Reno 1868 FC, University of Nevada, Reno, Assessment, Calcium, Boron, University, Element, UNR, Horizon Project, Earth science, ICP, Assistant professor, Sodium, Metallurgy, Partnership

CALGARY, Alberta, March 04, 2024 (GLOBE NEWSWIRE) -- Pan American Energy Corp. (CSE: PNRG | OTCQB: PAANF | FRA: SS60) ("Pan American” or the "Company") is pleased to announce it has partnered with the University of Nevada, Reno ("UNR") for comprehensive metallurgical testing on sedimentary and hard rock samples provided by the Company.

Key Points: 
  • CALGARY, Alberta, March 04, 2024 (GLOBE NEWSWIRE) -- Pan American Energy Corp. (CSE: PNRG | OTCQB: PAANF | FRA: SS60) ("Pan American” or the "Company") is pleased to announce it has partnered with the University of Nevada, Reno ("UNR") for comprehensive metallurgical testing on sedimentary and hard rock samples provided by the Company.
  • Jason Latkowcer, Chief Executive Officer, commented, “We are thrilled to announce our partnership with the esteemed University of Nevada, Reno, which is world renowned for its lithium expertise.
  • This partnership marks a significant stride towards the development of a preliminary economical assessment at the Horizon Lithium Project.
  • We will also benefit from UNR’s expertise in testing core samples from the Big Mack Lithium Project.

Wisconsin's Drive for $75M Towards Personalized Medicine Innovation

Retrieved on: 
Thursday, February 29, 2024
CHIPS, Senior, Entrepreneurship, Research, Medical college, Medical College of Wisconsin, Health, Growth, Economy, Data science, Phase II, EDA, Milwaukee Area Technical College, Madison College, Strategic planning, Patient, Automation, University City (Charlotte neighborhood), GE HealthCare, University of Wisconsin–Madison, Health equity, State, Science, Workforce, Assistant professor, Pathway

Image-Guided Therapy Data-Centric Patient Care Pathway- streamlines the integration of new technologies into healthcare systems, supporting the growth of theranostics and driving innovation in personalized medicine.

Key Points: 
  • Image-Guided Therapy Data-Centric Patient Care Pathway- streamlines the integration of new technologies into healthcare systems, supporting the growth of theranostics and driving innovation in personalized medicine.
  • Wisconsin Biohealth Tech Hub Governance- nurtures collaboration across projects, tracks metrics, and shares learnings, reinforcing the cycle of innovation and deployment.
  • "Receiving the Tech Hub designation was just the beginning," explains Wendy Harris , Regional Innovation Officer for the Wisconsin Biohealth Tech Hub .
  • "It recognizes Wisconsin's strengths in personalized medicine, biohealth technology, and precision manufacturing.

Provectus Biopharmaceuticals Announces Acceptance of Pharmaceutical-Grade Rose Bengal Sodium Abstract for Poster Presentation at 2024 Society for Investigative Dermatology (SID) Annual Meeting

Retrieved on: 
Thursday, February 29, 2024
UTHealth School of Dentistry, Division, Toxicity, Wound healing, ID, RBS, Society, Doctor of Philosophy, Safety, University, Control, Assistant professor, Surgery

KNOXVILLE, TN, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that data from ongoing preclinical research on the topical administration of a formulation of Provectus’s proprietary, pharmaceutical-grade, small molecule, rose bengal sodium (“RBS”) drug substance are being presented at the annual meeting of the Society for Investigative Dermatology (“SID”), to be held May 15-18, 2024 in Dallas, Texas.

Key Points: 
  • KNOXVILLE, TN, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that data from ongoing preclinical research on the topical administration of a formulation of Provectus’s proprietary, pharmaceutical-grade, small molecule, rose bengal sodium (“RBS”) drug substance are being presented at the annual meeting of the Society for Investigative Dermatology (“SID”), to be held May 15-18, 2024 in Dallas, Texas.
  • The accepted SID abstract is titled “Assessing the safety and toxicity of multi-dosed topical Rose Bengal Sodium (RBS) in a murine model of full-thickness cutaneous injury” (Control ID 4074036, Final ID 813, Current Category: Translational Studies and Early Preclinical to Clinical).
  • The work underlying this poster presentation is part of an ongoing sponsored research program with Amina El Ayadi, Ph.D., Assistant Professor, Division of Surgical Sciences, Department of Surgery at the University of Texas Medical Branch at Galveston to characterize the effects of RBS on full-thickness cutaneous wounds and during the subsequent phases of wound healing.

Quantum-Si and Researchers to Highlight the Power of Next-Generation Protein Sequencing™ on Platinum® at US HUPO Conference

Retrieved on: 
Thursday, March 7, 2024
Research, Technology, Other Health, Biotechnology, Hardware, Pharmaceutical, Health, Science, Oncology, Other Science, Molecule, Breakfast, PTM, Booth, Protein sequencing, Conference, Doctor of Philosophy, Protein, Johns Hopkins University, Mass spectrometry, Proteomics, Proteome, Assistant professor, Body modification, Hyatt Regency Portland, Microscope

WHAT: The Protein Sequencing Company™, Quantum-Si Incorporated , will showcase its Next-Generation Protein Sequencing™ instrument, Platinum®, and recent enhancements at the 20th Anniversary US HUPO Conference in Portland, Oregon on March 9-13.

Key Points: 
  • WHAT: The Protein Sequencing Company™, Quantum-Si Incorporated , will showcase its Next-Generation Protein Sequencing™ instrument, Platinum®, and recent enhancements at the 20th Anniversary US HUPO Conference in Portland, Oregon on March 9-13.
  • Additionally, researchers will present data from Platinum and highlight how protein sequencing on the benchtop instrument is providing deeper insights into proteins through streamlined workflows.
  • WHY: Quantum-Si brings the groundbreaking power of single-molecule proteomics with the first-to-market Next-Generation Protein Sequencer™, the Platinum instrument, to every lab, everywhere.
  • WHERE: The 2024 US HUPO Conference is being held at the Hyatt Regency Portland, 375 NE Holladay St, Portland, OR 97232

American Council of Learned Societies Names Inaugural ACLS HBCU Faculty Fellows and Grantees

Retrieved on: 
Thursday, February 29, 2024
Florida A&M University, Context, HBCU, ACLS, Division, American Council, Social, Multimedia, Morgan State University, Social justice, Friends, Learned society, Black nationalism, Faculty, Practice, Organization, Teaching, Knowledge, Black studies, History, Humanities, Assistant professor, Research, Outline of counseling, Education, Nursing

NEW YORK, Feb. 29, 2024 /PRNewswire/ -- The American Council of Learned Societies (ACLS) is pleased to announce the awardees of the new ACLS HBCU Faculty Fellowship and Grant Program. The program provides flexible support that attends to the research, teaching, and service commitments at Historically Black Colleges and Universities (HBCUs). This year, the program will support 20 HBCU faculty scholars pursuing exceptional research projects in the humanities and interpretive social sciences.

Key Points: 
  • NEW YORK, Feb. 29, 2024 /PRNewswire/ -- The American Council of Learned Societies (ACLS) is pleased to announce the awardees of the new ACLS HBCU Faculty Fellowship and Grant Program .
  • The ACLS HBCU Faculty Fellows and Grantees represent 16 HBCUs and a wide range of disciplines and scholarly approaches.
  • "We are thrilled to award these outstanding scholars the inaugural ACLS HBCU Faculty Fellowships and Grants," said ACLS President Joy Connolly.
  • Formed a century ago, the American Council of Learned Societies (ACLS) is a nonprofit federation of 80 scholarly organizations.

National Week of Prayer for the Healing of AIDS Streaming Discussion Series Centers Black Americans

Retrieved on: 
Tuesday, February 20, 2024
Seele, Community health, HIV/AIDS, Assistant professor, Research, Doctor of Philosophy, Multimedia, Education, Assistant, AIDS, Public health, Macedonia Baptist Church, Associate professor, HIV/AIDS research, Organization, Balm, Black, African Americans, Georgia Southern University, HIV, George Washington University

RICHMOND, Va., Feb. 20, 2024 /PRNewswire/ -- The National Week of Prayer for the Healing of AIDS, taking place March 3-9, will feature streaming discussions focusing on HIV/AIDS and Black Americans.

Key Points: 
  • RICHMOND, Va., Feb. 20, 2024 /PRNewswire/ -- The National Week of Prayer for the Healing of AIDS, taking place March 3-9, will feature streaming discussions focusing on HIV/AIDS and Black Americans.
  • National Week of Prayer for the Healing of AIDS, live streaming series, March 4-6, 2024.
  • Despite significant advances in HIV prevention and treatment methods, Black Americans represent 43% of new HIV diagnoses even though they are just 12% of the population.
  • The Balm In Gilead, Inc. is a 36-year-old organization whose mission is to equip faith communities serving Black Americans to become community hubs for health awareness, education, and support.